Lower riskDrug recall · FDA · Published February 5, 2024
Sun Pharmaceutical Mesalamine Capsules Recall: Failed Dissolution Specifications
Sun Pharmaceutical recalls 500mg Mesalamine Extended-Release Capsules due to failed dissolution specifications. This may affect drug effectiveness. Check NDC 63304-089-13 and lot numbers for affected batches.
“Sun Pharmaceutical Mesalamine Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32835-sun-pharmaceutical-mesalamine-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-0350-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0350-2024%22&limit=1).
The FDA announced on Feb. 5, 2024, that Sun Pharmaceutical is recalling Mesalamine Extended-Release Capsules due to failed dissolution specifications. The agency issued recall number D-0350-2024 for the voluntary Class II action.
The recall addresses Mesalamine Extended-Release Capsules that are out of specification for dissolution. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show SUN PHARMACEUTICAL INDUSTRIES INC has 93 other recalls on record since 2013-05-21. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (2026-09-14), Sun Pharmaceutical Carbamazepine Tablets Recall (2026-08-03), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (2026-06-17). Other recent recalls of similar products include Harvard Drug Group Memantine Capsules Recall (2026-03-24), AvKARE Amantadine Capsules Recall (2026-02-13), and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (2026-08-31).
How to tell if you have this one
Check the product label for NDC 63304-089-13 and lot numbers like MHD0606A through MHD1087A with specific expiration dates listed in the recall notice.
Brand
Sun Pharmaceutical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the NDC code 63304-089-13 and lot numbers listed in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 30 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0350-2024 (February 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0350-2024 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.